Table 1.
Clinical characteristics of the patients
| Mean±SD | Evaluated patients, n | |
|---|---|---|
| Age, years | 63±13 | 2,107 |
| Males, % | 62 | 2,107 |
| Duration of diabetes mellitus, years | 9±10 | 1,794 |
| Current smokers, % | 35 | 1,647 |
| Treatment for diabetes mellitus | ||
| Diet only/OHA/insulin, % | 17/56/27 | 2,107 |
| Body mass index | 24.9±4.3 | 2,078 |
| Obesity, % | 44 | 2,078 |
| HbA1c, % | 8.4±2.2 | 1,964 |
| Hypertension, % | 70 | 2,107 |
| Systolic blood pressure, mm Hg | 138±21 | 2,107 |
| Diastolic blood pressure, mm Hg | 80±14 | 2,107 |
| Hypercholesterolemia, % | 61 | 2,102 |
| Total cholesterol, mmol/l | 5.2±1.2 | 1,800 |
| LDL cholesterol, mmol/l | 3.2±1.0 | 1,427 |
| Hypo-HDL-cholesterolemia, % | 13 | 1,598 |
| HDL cholesterol, mmol/1 | 1.5±0.4 | 1,598 |
| Serum creatinine, μmol/l | 86±51 | 2,107 |
| Estimated GFR, ml/min/1.73 m2 | 55±20 | 2,107 |
| GFR stage, % G1/G2/G3a/G3b/G4/G5 | 5/32/34/20/7/2 | 2,107 |
| Albuminuria stage, % A1/A2/A3 | 53/24/23 | 2,027 |
| Hyperuricemia, % | 21 | 2,096 |
| Serum uric acid, μmol/l | 307±89 | 2,096 |
| Anemia, % | 26 | 2,101 |
| Hemoglobin, g/dl | 135±17 | 2,101 |
| Diabetic retinopathy1, % | 40 | 1,588 |
| Diabetic neuropathy, % | 68 | 1,575 |
| Cerebrovascular disease, % | 13 | 2,106 |
| Coronary heart disease, % | 19 | 2,105 |
| Peripheral arterial disease, % | 5 | 2,107 |
OHA = Oral hypoglycemic agents.
1
Diabetic retinopathy includes simple, preproliferative and proliferative retinopathies.